Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
57.86
+0.98 (1.72%)
At close: Feb 6, 2026, 4:00 PM EST
56.00
-1.86 (-3.21%)
After-hours: Feb 6, 2026, 6:26 PM EST
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $385.92 million as of February 6, 2026. Its market cap has increased by 60.94% in one year.
Market Cap
385.92M
Enterprise Value
242.35M
1-Year Change
60.94%
Ranking
Category
Stock Price
$57.86
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $385.92M, an increase of 39.75%. That is a compound annual growth rate of 5.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 385.92M | -11.56% |
| Dec 31, 2025 | 436.37M | 225.25% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 405.25M |
| Greenwich LifeSciences | 401.78M |
| Bicycle Therapeutics | 392.62M |
| Enanta Pharmaceuticals | 392.04M |
| Aclaris Therapeutics | 386.79M |
| Entrada Therapeutics | 380.13M |
| Allogene Therapeutics | 379.79M |
| Autolus Therapeutics | 377.92M |